Showing 1 - 10 of 12
Persistent link: https://www.econbiz.de/10011754232
Persistent link: https://www.econbiz.de/10011597003
Persistent link: https://www.econbiz.de/10013383726
Persistent link: https://www.econbiz.de/10014253466
The World Trade Organization (WTO) recently ruled on the case brought by the US, Canada and Argentina against the moratorium imposed by the European Union (EU) on imports of genetically-modified (GM) food and crops. Although the WTO's ruling has been greeted by the complainant countries as a...
Persistent link: https://www.econbiz.de/10005557053
Purpose: The purpose of this paper is to add to the existing wealth of knowledge on the benefits and challenges of social entrepreneurship in Egypt, a challenging emerging economy. Design/methodology/approach: The research combines secondary and primary research with the latter including...
Persistent link: https://www.econbiz.de/10012186917
Persistent link: https://www.econbiz.de/10012191106
Background: Natalizumab (Tysabri(R)) is a new disease-modifying therapy that has been shown to be clinically effective in patients with relapsing-remitting multiple sclerosis (RRMS) and has been licensed for use in patients with highly active RRMS (HARRMS). These patients are those who...
Persistent link: https://www.econbiz.de/10005404771
If UK society is willing to pay more than £8200 per QALY, or Health and Social Services are willing to pay more than £26 000 per QALY, this analysis suggests that natalizumab is likely to be a cost-effective treatment for all patients with HARRMS. </AbstractSection> Copyright Adis Data Information BV 2008
Persistent link: https://www.econbiz.de/10011001431
Futures market clearinghouses are intermediaries that make large volume trading between anonymous parties feasible. During the October 1987 market crash rumors spread that a major clearinghouse might fail. This paper presents estimates of three measures of the default exposure on the popular...
Persistent link: https://www.econbiz.de/10005714503